
Azra Raza
Oncologist, author of "The First Cell." Professor of medicine and director of the MDS Center at Columbia University.
Top 3 podcasts with Azra Raza
Ranked by the Snipd community

16 snips
Jul 27, 2020 • 1h 55min
#121 - Azra Raza, M.D.: Why we're losing the war on cancer
Azra Raza, a leading physician and author, passionately advocates for a paradigm shift in cancer research. She critiques outdated models that hinder progress in survival rates and discusses her book, 'The First Cell.' Highlighting the staggering costs of new cancer drugs, she questions the efficacy of current treatments while pushing for a focus on early detection and prevention. Azra shares her personal journey and the emotional toll of her husband's battle with cancer, ultimately offering an optimistic vision for the future of oncology.

15 snips
Sep 14, 2024 • 1h 7min
The Broken State Of Cancer Research, Cancer Detection & Cancer Drugs (& What We Can DO About It!) With Dr. Azra Raza.
Dr. Azra Raza, a dedicated oncologist and professor at Columbia University, dives deep into the failures of current cancer research and exciting advancements in early detection. She shares her groundbreaking focus on detecting 'The First Cell' and the potential of biomarkers and wearable devices. Dr. Raza opens up about her late husband's battle with cancer, which propelled her into patient advocacy. The discussion also critiques the traditional cancer drug development model, advocating for a more patient-centered approach and substantial funding for innovative research.

Mar 23, 2020 • 1h 25min
Azra Raza on The First Cell
Azra Raza, an oncologist and author of "The First Cell," shares her insights on the stagnant progress in cancer treatment over the past five decades. She critiques traditional methods, advocating for a more holistic approach to cancer that considers individual complexities. Raza discusses the emotional aspects of patient care, highlighting the importance of listening and the often-unspoken challenges oncologists face. She also emphasizes the need for innovative research and compassionate engagement to truly understand and treat this multifaceted disease.